The leading industry associations have signed a Memorandum of Understanding
December 29, 2016
On December 28, 2016 at the National Medical Chamber a Memorandum of Understanding was officially signed between the leading industry associations of Russia: The National Medical Chamber, represented by President Leonid Roshal; the National Pharmaceutical Chamber, represented by Executive Director Elena Nevolina; the Association of Russian Pharmaceutical Manufacturers, represented by General Director Viktor Dmitriev; the Association of International Pharmaceutical Manufacturers, represented by Executive Director Vladimir Shipkov; the Association “Rosmedprom”, represented by President Yuriy Kalinin; the International Medical Device Manufacturers Association, represented by Executive Director Sergey Kolosov; and National Immunobiological Company represented by General Director Mariam Khubieva.
EDL “Freezing”: manufacturers and patients need to melt the ice
Last Friday, the press center of ITAR-TASS hosted a press briefing “Ice Age for Patients?”, devoted to the possible suspension of revising of the essential drug list (EDL) and list of drugs to provide certain categories of citizens (ONLS), which was announced by the representatives of the Ministry of Healthcare in the media. Following the meetings of the Commission of the Ministry of Healthcare of Russia on the formation of drug lists, the inclusion into the draft of EDL for 2017 of 24 medicines that have passed expert review and been recommended for inclusion was called into question. Concerned representatives of patient and medical societies, as well as the pharmaceutical industry, invited the Ministry of Healthcare to an open discussion on the burning question.
Introducing company interests, on which share it is necessary about 80 % made and sold in the world of pharmaceutical production and the medical equipment, AIPM considers as the priority cooperation with the Russian bodies of public health services, and also with legislative and executive branches of the power, for the purpose of working out of the program of creation of favorable conditions for sale and-or production of the international pharmaceutical companies in territory of the Russian Federation